UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051428
Receipt number R000058656
Scientific Title Hokuriku-Plus Acute Decompensation Heart Failure Registry
Date of disclosure of the study information 2023/07/01
Last modified on 2023/06/23 08:32:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Hokuriku-Plus Acute Decompensation Heart Failure Registry

Acronym

Hokuriku-Plus Acute Decompensation Heart Failure Registry

Scientific Title

Hokuriku-Plus Acute Decompensation Heart Failure Registry

Scientific Title:Acronym

Hokuriku-Plus Acute Decompensation Heart Failure Registry

Region

Japan


Condition

Condition

Acute Decompensation Heart Failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the actual situation of acute noncompensated heart failure in actual clinical practice in the Hokuriku region.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Death (cardiovascular and non-cardiovascular)

Key secondary outcomes

Hospitalization for cardiovascular causes (heart failure, acute myocardial infarction, stroke, other), hospitalization for heart failure
Hospitalization for any cause, changes in blood BNP levels, changes in echocardiographic findings,
mRNA expression analysis of blood cells


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with acute decompensated heart failure

Key exclusion criteria

(1) Patients after heart transplantation
(2) Patients with acute coronary syndrome requiring urgent revascularization
(3) Other patients who are judged by the physician in charge to be inappropriate as research subjects.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Soichiro
Middle name
Last name Usui

Organization

Kanazawa University

Division name

Department of Cardiovascular Medicine

Zip code

9208641

Address

13-1 Takaramachi, Kanazawa, Ishikawa, Japan

TEL

0762652259

Email

usuiso@staff.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name Soichiro
Middle name
Last name Usui

Organization

Kanazawa University

Division name

Department of Cardiovascular Medicine

Zip code

9208641

Address

13-1 Takaramachi, Kanazawa, Ishikawa

TEL

0762652259

Homepage URL


Email

usuiso@staff.kanazawa-u.ac.jp


Sponsor or person

Institute

Kanazawa University

Institute

Department

Personal name

Soichiro Usui


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Ethics Committee of Kanazawa University

Address

13-1 Takaramachi Kanazawa, Ishikawa, Japan

Tel

0762652110

Email

rinri@adm.kanazawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 09 Month 18 Day

Date of IRB

2020 Year 09 Month 18 Day

Anticipated trial start date

2020 Year 09 Month 18 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observations, tests, and reportable items
Basic items: date of birth (A.D.), sex, height, weight, social factors (living alone, living with others, welfare status), heart failure stage classification (C or D)
Physical examination (on admission): severity (NYHA cardiac function classification), type of clinical scenario (CS; 1,2,3,4,5), blood pressure, pulse rate, respiratory rate, presence of leg edema.
Family history: presence or absence of family history.
Preference history: presence or absence of smoking.
Comorbidities:
Severity of illness (at discharge): NYHA classification, clinical frailty scale, grip strength, AT level, 6-minute walk distance
Laboratory findings: general blood tests, ECG, echocardiography
PAXgene Blood RNA


Management information

Registered date

2023 Year 06 Month 23 Day

Last modified on

2023 Year 06 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058656


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name